Molecular Insights into HIV-1 Infection
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Human Virology and Viral Diseases".
Deadline for manuscript submissions: 31 December 2026 | Viewed by 21
Special Issue Editor
Special Issue Information
Dear Colleagues,
The FDA’s approval of Lenacapavir, a long-acting HIV-1 prevention drug has marked the year 2025 as a significant milestone in anti-retroviral therapy. Recent advancements and breakthroughs in HIV-1 molecular biology have intensified the race to achieve the development of a complete cure for AIDS. A better understanding of the complex interplay between virus and host cell factors at the molecular level will contribute to developing more effective therapeutic strategies.
This Special Issue, “Molecular Insights into HIV-1 Infection”, seeks manuscripts that investigate the crucial steps of the HIV-1 lifecycle; virus entry into host cell, nuclear trafficking, integration, latency, assembly, egress, and maturation. We additionally encourage the submission of papers that explore the latest technology in this field used to develop novel drug molecules or anti-HIV-1 strategies. Review articles on recent developments in our understanding of HIV-1 biology are also welcome.
We look forward to receiving your submissions, hoping to contribute to the development of innovative strategies against HIV-1.
Dr. Satya Prakash Singh
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HIV-1 replication
- host factors
- nuclear translocation and integration
- HIV-1 latency and immune response
- anti-HIV-1 strategies
- techniques in HIV research
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
